HIPINE (02583) · Company profile · Eqvero

HIPINE

02583HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	610.84 m CNY	456.56 m CNY	445.48 m CNY	323.7 m CNY	454.46 m CNY
Cost of revenue	417.39 m CNY	332.29 m CNY	337.74 m CNY	258.17 m CNY	345.75 m CNY
Research and development expense	13.08 m CNY	11.79 m CNY	13.49 m CNY	8.45 m CNY	13.64 m CNY
Selling, general and administrative expense	37.74 m CNY	32.22 m CNY	28.6 m CNY	21.69 m CNY	22.59 m CNY
Operating profit after depreciation	136.26 m CNY	74.61 m CNY	59.52 m CNY	27.1 m CNY	69.59 m CNY
Operating profit before depreciation	140.21 m CNY	78.21 m CNY	63.47 m CNY	31.65 m CNY	72.12 m CNY
EBIT	136.26 m CNY	74.61 m CNY	59.52 m CNY	27.1 m CNY	69.59 m CNY
EBITDA	140.21 m CNY	78.21 m CNY	63.47 m CNY	31.65 m CNY	72.12 m CNY
Interest expense	5.55 m CNY	4.88 m CNY	4.75 m CNY	3.72 m CNY	—
Profit before tax	124.12 m CNY	58.66 m CNY	59.9 m CNY	27.82 m CNY	67.54 m CNY
Income tax expense	22.23 m CNY	9.31 m CNY	7.8 m CNY	3.28 m CNY	8.69 m CNY
Income before extraordinary items	101.9 m CNY	49.35 m CNY	52.1 m CNY	24.54 m CNY	58.85 m CNY
Common dividends	—	20.26 m CNY	24.11 m CNY	24.35 m CNY	—
Total dividends	—	20.26 m CNY	24.11 m CNY	24.35 m CNY	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.